Healthcare

Clinical Trial Supplies Market worth $8.95 billion by 2031 - Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Oct. 2, 2026, 10:30 GMT-04

MarketsandMarkets

Read full article →

Smartee Marks European Milestone with First Regional Summit in Mallorca

PALMA DE MALLORCA, Spain, Oct. 2, 2026, 08:02 GMT-04

Smartee-Denti-Technol

Read full article →

Emboline Announces First U.S. Commercial Use of the Emboliner® Embolic Protection System

SANTA CRUZ, Calif., Oct. 2, 2026, 08:00 GMT-04

Emboline-Inc

Read full article →

Closing the gap between approval and access: Taiwan's PatientsForce wins Silver at the Global Good Awards 2026

LONDON and TAIPEI, Oct. 2, 2026, 06:13 GMT-04

PatientsForce

Read full article →

Quotient Sciences and Acesion Pharma Announce Collaboration on AI-Enhanced Formulation Development to Advance Atrial Fibrillation Pipeline

NOTTINGHAM, England, Oct. 2, 2026, 05:51 GMT-04

Quotient-Sciences

Read full article →

PhytoHealth CEO Angel Lee Recognized for Driving the Advancement of World's First Prescription Drug for Cancer-Related Fatigue

TAIPEI, Oct. 2, 2026, 04:11 GMT-04

PhytoHealth-Corp

Read full article →

Lundbeck to showcase progress across its movement disorders pipeline with data in multiple system atrophy and Parkinson's disease at MDS® 2026

VALBY, Denmark, 2 October 2026, 02:31 GMT-04

H-Lundbeck-AS

Read full article →

Skanska signs additional contract for new hospital in Fort Myers, Florida, USA, for USD 60M, about SEK 560M

STOCKHOLM, Oct. 2, 2026, 02:13 GMT-04

Skanska

Read full article →

Samfara completes acquisition of Chr. Olesen Synthesis, Danish manufacturer of controlled-substance APIs

LONDON, Oct. 2, 2026, 02:00 GMT-04

Samfara-LLP

Read full article →

Abogen Announces Licensing and Option Agreement with Novartis to Advance mRNA-Encoded T-Cell Engager and other potential RNA programs

SUZHOU, China, Oct. 2, 2026, 01:19 GMT-04

Abogen

Read full article →

19.3% Weight Loss at Week 48: Phase Ⅲ Data of Olatorepatide, Hansoh's Dual‑Biased GLP‑1/GIP Agonist, Presented at EASD

MILAN, Oct. 2, 2026, 00:00 GMT-04

Hansoh-Pharma

Read full article →

Uriage Presents New Scientific Advances in Triple Barrier Science at EADV Congress 2026 in Vienna

PARIS, Oct. 1, 2026, 15:18 GMT-04

Laboratoires-Dermatol

Read full article →

82-Year-Old Dr. Judy Benjamin traversed southern England to share her story and advocate for families affected by Alzheimer's

LONDON, Oct. 1, 2026, 13:41 GMT-04

Apollo-Health

Read full article →

Fabry Disease Market Outlook: 6 Upcoming Therapies Set to Influence the Future Market Landscape | DelveInsight

LAS VEGAS, Oct. 1, 2026, 10:31 GMT-04

DelveInsight-Business

Read full article →

Healthcare Supply Chain Management Market worth $5.31 billion by 2031 - Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Oct. 1, 2026, 10:30 GMT-04

MarketsandMarkets

Read full article →

A Formidable Type of Childhood Cancer Gets Added to Highly Regarded Library of Treatment Recommendations

PLYMOUTH MEETING, Pa., Oct. 1, 2026, 09:36 GMT-04

NCCN

Read full article →

Waters Corporation Schedules Third Quarter 2026 Earnings Conference Call

MILFORD, Mass., Oct. 1, 2026, 09:00 GMT-04

Waters-Corporation

Read full article →

Medline launches "10 Minutes That Matter" campaign to spotlight the value of time in the operating theatre

UTRECHT, Netherlands, Oct. 1, 2026, 07:31 GMT-04

Medline-EMEA

Read full article →

HelpMeSee Names Doug May President and Chief Executive Officer

JERSEY CITY, N.J., Oct. 1, 2026, 07:07 GMT-04

Help-Me-See

Read full article →

Lutris Pharma Announces Positive Updated Phase 2 Data Demonstrating Durable, Mechanism-Directed Benefit of LUT014 Gel for EGFRI-Induced Acneiform Rash at the EADV Congress

TEL AVIV, Israel, Oct. 1, 2026, 07:03 GMT-04

Lutris-Pharma

Read full article →